Page 37 - Vitro Diagnostics News Today

Share: New York, April 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hepatitis C Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" - https://www.reportlinker.com/p05948864/?utm_source=GNW The model discusses in detail the impact of COVID-19 on Hepatitis C Tests market for the year 2020 and beyond.Hepatitis C is a viral infection caused by hepatitis C virus (HCV). Hepatitis C virus is a blood borne virus that...

Share: New York, April 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "PCR Systems (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" - https://www.reportlinker.com/p05948874/?utm_source=GNW The model discusses in detail the impact of COVID-19 on PCR Systems market for the year 2020 and beyond. PCR Systems are used for diagnosis and screening of a wide array of infectious disease as well as for testing of cancer pati...

Share: New York, April 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hepatitis B Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" - https://www.reportlinker.com/p05948863/?utm_source=GNW The model discusses in detail the impact of COVID-19 on Hepatitis B Tests market for the year 2020 and beyond.Hepatitis B is a common cause of liver disease across the globe, and remains a major issue for most of the govern...

Share: New York, April 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Diabetes Assays (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" - https://www.reportlinker.com/p05948858/?utm_source=GNW The model discusses in detail the impact of COVID-19 on Diabetes Assays market for the year 2020 and beyond.Diabetes Assays are performed to diagnose individuals at higher risk of developing the disease. Tests that are perfor...

Share: New York, April 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "BRAF Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" - https://www.reportlinker.com/p05948850/?utm_source=GNW The model discusses in detail the impact of COVID-19 on BRAF Tests market for the year 2020 and beyond. Melanoma is accounted for as the nineteenth most basic malignant growth around the world, with assessed age-standardized frequ...

Share: New York, April 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "HER2 Amplification Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" - https://www.reportlinker.com/p05948865/?utm_source=GNW The model discusses in detail the impact of COVID-19 on HER2 Amplification Tests market for the year 2020 and beyond.Breast cancer is the most frequent cancer in women and is now the leading cause of female cancer-re...

Share: New York, April 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "ALK Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" - https://www.reportlinker.com/p05948847/?utm_source=GNW The model discusses in detail the impact of COVID-19 on ALK Tests market for the year 2020 and beyond.Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. Secondary sources estima...

Share: New York, March 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Helicobacter Pylori Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)" - https://www.reportlinker.com/p06000506/?utm_source=GNW The model discusses in detail the impact of COVID-19 on Helicobacter Pylori Tests market for the year 2020 and beyond. H. pylori has been recognized as a Class I carcinogen by the International Agency for Research o...

Modern Healthcare Illustration / Getty Images With rapid antigen tests for SARS-CoV-2 slow to come to market, officials at the US Food and Drug Administration have tried to signal via a number of public comments that the agency would be flexible regarding test performance requirements and use models. These indications of flexibility have largely failed to speed development and commercialization of rapid antigen tests, however, as test vendors, wary of falling short of agency requirements, have ...

Industry Liaison Forum Industry Liaison Forum (ILF) MISSION: Promote and facilitate the contribution of the biomedical industry to the global HIV response, focusing on expediting development and approval of HIV diagnostics and medicines. The past decade has been marked by rapid advances in HIV research, leading to the introduction of more efficacious and client-friendly interventions for treating people living with HIV and preventing the further spread of the virus. Critical gaps remain in the...